Related Experiment Video
Updated: Feb 15, 2026

Continuous Noninvasive Measuring of Crayfish Cardiac and Behavioral Activities
Published on: February 6, 2019
Dexmedetomidine as Single Continuous Sedative During Noninvasive Ventilation: Typical Usage, Hemodynamic Effects, and
Brittany L Shutes1, Samantha W Gee1, Cheryl L Sargel2
1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Nationwide Children's Hospital & The Ohio State University College of Medicine, Columbus, OH.
Prolonged dexmedetomidine sedation in pediatric critical care showed predictable hemodynamic effects like bradycardia and hypertension. Withdrawal symptoms, linked to cumulative dose, were managed with enteral clonidine.
Area of Science:
- Pediatric Critical Care Medicine
- Pharmacology
- Clinical Therapeutics
Background:
- The use of dexmedetomidine for sedation in pediatric intensive care units (PICUs) is increasing.
- Its prolonged effects as a sole continuous sedative agent require further description, particularly regarding hemodynamic stability and withdrawal.
- Understanding these aspects is crucial for optimizing patient care and safety.
Purpose of the Study:
- To describe the hemodynamic effects of prolonged dexmedetomidine therapy when used as the sole continuous sedative agent in pediatric patients.
- To analyze discontinuation strategies and identify risk factors associated with dexmedetomidine withdrawal.
- To provide insights into managing withdrawal symptoms in this population.
Main Methods:
- A retrospective chart review was conducted at a single-center, quaternary care pediatric academic institution.
- Data were collected from 382 children under 18 years old admitted to the PICU who received dexmedetomidine for over 24 hours without other continuous sedatives during noninvasive positive pressure ventilation.
- Discontinuation methods included abrupt cessation, weaning, and transition to enteral clonidine.
Main Results:
- Prolonged dexmedetomidine use (median 45 hours) resulted in predictable hemodynamic changes, including bradycardia (28%) and hypertension (33%) after reaching peak dose.
- During the escalation phase, higher rates of bradycardia (75%) and hypotension (30%) were observed.
- Withdrawal symptoms occurred in 5% of patients, with cumulative dose being a significant risk factor (OR 1.3 per 10 μg/kg).
Conclusions:
- Dexmedetomidine as a sole continuous sedative in pediatric critical care is associated with predictable hemodynamic effects.
- While withdrawal is linked to cumulative dose, symptoms were effectively managed with short-term enteral clonidine.
- This study provides valuable data for the safe and effective use of prolonged dexmedetomidine sedation in pediatric patients.
More Related Videos
Related Concept Videos
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Typical Model Studies
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...

